Thomas Catinazzo's most recent trade in Relay Therapeutics Inc was a trade of 12,943 Common Stock done at an average price of $3 . Disclosure was reported to the exchange on April 28, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.00 per share. | 28 Apr 2025 | 12,943 | 355,376 | - | 3 | 38,829 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.23 per share. | 28 Apr 2025 | 3,558 | 368,319 | - | 3.2 | 11,492 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.17 per share. | 28 Apr 2025 | 1,709 | 372,858 | - | 3.2 | 5,418 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 3.17 per share. | 28 Apr 2025 | 981 | 371,877 | - | 3.2 | 3,110 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.84 per share. | 27 Mar 2025 | 4,566 | 374,567 | - | 2.8 | 12,967 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.84 per share. | 27 Mar 2025 | 298 | 379,133 | - | 2.8 | 846 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 139,141 | 402,331 | - | 0 | Common Stock | |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.63 per share. | 28 Jan 2025 | 33,753 | 265,473 | - | 4.6 | 156,276 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.42 per share. | 28 Jan 2025 | 20,791 | 379,431 | - | 4.4 | 91,896 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.63 per share. | 28 Jan 2025 | 2,283 | 263,190 | - | 4.6 | 10,570 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.55 per share. | 28 Jan 2025 | 2,109 | 400,222 | - | 4.6 | 9,596 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jan 2025 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.42 per share. | 27 Dec 2024 | 4,566 | 299,226 | - | 4.4 | 20,182 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.38 per share. | 27 Dec 2024 | 299 | 303,792 | - | 4.4 | 1,310 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.06 per share. | 28 Oct 2024 | 5,105 | 306,391 | - | 6.1 | 30,936 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 5.95 per share. | 28 Oct 2024 | 2,300 | 304,091 | - | 6.0 | 13,685 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.06 per share. | 28 Oct 2024 | 1,697 | 311,496 | - | 6.1 | 10,284 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.46 per share. | 27 Sep 2024 | 6,162 | 313,193 | - | 7.5 | 45,969 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.51 per share. | 27 Sep 2024 | 295 | 319,355 | - | 7.5 | 2,215 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.51 per share. | 29 Jul 2024 | 9,078 | 319,650 | - | 8.5 | 77,254 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 8.85 per share. | 29 Jul 2024 | 1,702 | 328,728 | - | 8.9 | 15,063 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.24 per share. | 27 Jun 2024 | 9,078 | 330,430 | - | 6.2 | 56,647 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.26 per share. | 27 Jun 2024 | 295 | 339,508 | - | 6.3 | 1,847 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.38 per share. | 29 Apr 2024 | 1,695 | 339,803 | - | 6.4 | 10,814 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 7.70 per share. | 27 Mar 2024 | 348 | 341,498 | - | 7.7 | 2,680 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 9.64 per share. | 29 Jan 2024 | 2,005 | 341,846 | - | 9.6 | 19,328 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jan 2024 | 200,000 | 343,851 | - | 0 | Common Stock | |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.51 per share. | 27 Dec 2023 | 294 | 143,851 | - | 11.5 | 3,384 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.80 per share. | 28 Jul 2023 | 1,693 | 146,136 | - | 11.8 | 19,977 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 12.12 per share. | 27 Jun 2023 | 294 | 147,829 | - | 12.1 | 3,563 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 11.16 per share. | 28 Apr 2023 | 2,012 | 148,123 | - | 11.2 | 22,454 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 15.36 per share. | 27 Mar 2023 | 347 | 150,135 | - | 15.4 | 5,330 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 21.56 per share. | 30 Jan 2023 | 864 | 150,482 | - | 21.6 | 18,628 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 104,600 | 104,600 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 101,115 | 151,346 | - | 0 | Common Stock | |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 97,630 | 97,630 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 14.49 per share. | 27 Dec 2022 | 445 | 50,231 | - | 14.5 | 6,448 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 21.54 per share. | 28 Oct 2022 | 1,099 | 50,676 | - | 21.5 | 23,672 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 22.73 per share. | 27 Sep 2022 | 443 | 51,775 | - | 22.7 | 10,069 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 08 Sep 2022 | 26,257 | 52,218 | - | 30 | 787,710 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2022 | 26,257 | 0 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 08 Sep 2022 | 26,257 | 78,475 | - | 4.1 | 108,179 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 21.26 per share. | 28 Jul 2022 | 734 | 52,218 | - | 21.3 | 15,605 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 20.31 per share. | 27 Jun 2022 | 300 | 52,952 | - | 20.3 | 6,093 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 25.57 per share. | 28 Apr 2022 | 725 | 53,252 | - | 25.6 | 18,538 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 29.87 per share. | 29 Mar 2022 | 282 | 53,977 | - | 29.9 | 8,423 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 24 Mar 2022 | 13,286 | 67,545 | - | 4.1 | 54,738 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Mar 2022 | 13,286 | 26,257 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 30.00 per share. | 24 Mar 2022 | 13,286 | 54,259 | - | 30 | 398,580 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 78,540 | 78,540 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Thomas Catinazzo | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 39,270 | 54,259 | - | 0 | Common Stock | |
| Relay Therapeutics Inc | Thomas Catinazzo | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 33.10 per share. | 27 Dec 2021 | 295 | 14,989 | - | 33.1 | 9,765 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Senior Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 15 Nov 2021 | 22,500 | 37,784 | - | 4.1 | 92,700 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Senior Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2021 | 22,500 | 39,543 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Thomas Catinazzo | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 35.40 per share. | 15 Nov 2021 | 22,500 | 15,284 | - | 35.4 | 796,500 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 36.87 per share. | 27 Sep 2021 | 293 | 15,284 | - | 36.9 | 10,803 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Senior Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 13 Sep 2021 | 22,500 | 38,077 | - | 4.1 | 92,700 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Senior Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Sep 2021 | 22,500 | 62,043 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Thomas Catinazzo | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 13 Sep 2021 | 22,500 | 15,577 | - | 35 | 787,500 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 35.81 per share. | 28 Jun 2021 | 293 | 15,577 | - | 35.8 | 10,492 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Senior Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 07 Jun 2021 | 22,500 | 38,370 | - | 4.1 | 92,700 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Senior Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2021 | 22,500 | 84,543 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Thomas Catinazzo | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 07 Jun 2021 | 22,500 | 15,870 | - | 35 | 787,500 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Senior Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.12 per share. | 30 Mar 2021 | 22,500 | 38,370 | - | 4.1 | 92,700 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Senior Vice President, Finance | Sale of securities on an exchange or to another person at price $ 35.00 per share. | 30 Mar 2021 | 22,500 | 15,870 | - | 35 | 787,500 | Common Stock |
| Relay Therapeutics Inc | Thomas Catinazzo | Senior Vice President, Finance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2021 | 22,500 | 107,043 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Thomas Catinazzo | Senior Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2021 | 31,740 | 31,740 | - | - | Stock Option (Right to Buy) | |
| Relay Therapeutics Inc | Thomas Catinazzo | Senior Vice President, Finance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Mar 2021 | 15,870 | 15,870 | - | 0 | Common Stock |